RPG LIFE SCIENCES
Quarterly Results Analysis [Dec2024]
RPG LIFE SCIENCES Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹173 Cr | ₹172 Cr | ₹165 Cr | ₹127 Cr | ₹154 Cr | ₹154 Cr | ₹148 Cr | ₹118 Cr |
Expenses | ₹124 Cr | ₹126 Cr | ₹126 Cr | ₹106 Cr | ₹116 Cr | ₹116 Cr | ₹116 Cr | ₹103 Cr |
Operating Income | ₹49 Cr | ₹46 Cr | ₹39 Cr | ₹21 Cr | ₹38 Cr | ₹37 Cr | ₹32 Cr | ₹16 Cr |
Other Income | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
Profit Before Tax | ₹47 Cr | ₹15 Cr | ₹36 Cr | ₹18 Cr | ₹36 Cr | ₹35 Cr | ₹30 Cr | ₹14 Cr |
Profit After Tax | ₹35 Cr | ₹4 Cr | ₹27 Cr | ₹13 Cr | ₹26 Cr | ₹26 Cr | ₹22 Cr | ₹10 Cr |
EPS | ₹21.12 | ₹2.54 | ₹16.18 | ₹8.01 | ₹16.00 | ₹15.64 | ₹13.36 | ₹6.26 |
Industry Peers & Returns | 1W | 1M | 1Y |
RPG LIFE SCIENCES | -4.2% | 4.1% | 49.1% |
SUN PHARMACEUTICAL INDUSTRIES | -1.5% | 9.1% | 9.1% |
DIVIS LABORATORIES | -4.9% | -0.6% | 59.1% |
CIPLA | -1.8% | 1% | 0.5% |
TORRENT PHARMACEUTICALS | 1.6% | 12.1% | 21.8% |
DR REDDYS LABORATORIES | -3% | -0.9% | -7.7% |
MANKIND PHARMA | 1.1% | 7.6% | 1.3% |
ZYDUS LIFESCIENCES | -2.2% | -0.6% | -9.3% |
LUPIN | -2.7% | 1% | 30.1% |
RPG LIFE SCIENCES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 0.29 % |
Y-o-Y | 12.37 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹173 Cr | 0.29 | |
Sep2024 | ₹172 Cr | 4.10 | |
Jun2024 | ₹165 Cr | 30.26 | |
Mar2024 | ₹127 Cr | -17.38 | |
Dec2023 | ₹154 Cr | 0.08 | |
Sep2023 | ₹154 Cr | 3.92 | |
Jun2023 | ₹148 Cr | 24.72 | |
Mar2023 | ₹118 Cr | - |
RPG LIFE SCIENCES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 7.03 % |
Y-o-Y | 29.71 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹49 Cr | 7.03 | |
Sep2024 | ₹46 Cr | 17.56 | |
Jun2024 | ₹39 Cr | 88.56 | |
Mar2024 | ₹21 Cr | -45.33 | |
Dec2023 | ₹38 Cr | 1.64 | |
Sep2023 | ₹37 Cr | 15.66 | |
Jun2023 | ₹32 Cr | 102.64 | |
Mar2023 | ₹16 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 6.71 % |
Y-o-Y | 15.41 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 28.46% | 6.71 | |
Sep2024 | 26.67% | 12.91 | |
Jun2024 | 23.62% | 44.73 | |
Mar2024 | 16.32% | -33.82 | |
Dec2023 | 24.66% | 1.57 | |
Sep2023 | 24.28% | 11.27 | |
Jun2023 | 21.82% | 62.47 | |
Mar2023 | 13.43% | - |
RPG LIFE SCIENCES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 731.67 % |
Y-o-Y | 32.01 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹35 Cr | 731.67 | |
Sep2024 | ₹4 Cr | -84.30 | |
Jun2024 | ₹27 Cr | 102.11 | |
Mar2024 | ₹13 Cr | -49.96 | |
Dec2023 | ₹26 Cr | 2.32 | |
Sep2023 | ₹26 Cr | 17.01 | |
Jun2023 | ₹22 Cr | 113.53 | |
Mar2023 | ₹10 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 728.69 % |
Y-o-Y | 17.42 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 20.22 % | 728.69 | |
Sep2024 | 2.44 % | -84.92 | |
Jun2024 | 16.18 % | 55.13 | |
Mar2024 | 10.43 % | -39.43 | |
Dec2023 | 17.22 % | 2.26 | |
Sep2023 | 16.84 % | 12.64 | |
Jun2023 | 14.95 % | 71.25 | |
Mar2023 | 8.73 % | - |
RPG LIFE SCIENCES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 731.50 % |
Y-o-Y | 32.00 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹21.12 | 731.50 | |
Sep2024 | ₹2.54 | -84.30 | |
Jun2024 | ₹16.18 | 102.00 | |
Mar2024 | ₹8.01 | -49.94 | |
Dec2023 | ₹16 | 2.30 | |
Sep2023 | ₹15.64 | 17.07 | |
Jun2023 | ₹13.36 | 113.42 | |
Mar2023 | ₹6.26 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD